Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide
XTalks
JUNE 8, 2022
In a press release , the company says the goal of the Act4Biosimilars campaign is to help “address global health inequity and inequality” by increasing access to advanced medicines like biosimilars. On average, biosimilars are about 30 percent cheaper than original branded biologics, with expectations that they could become even cheaper. “As
69 
Let's personalize your content